You have almost certainly never heard of Thelma, or met her, or know anything about her. She’s a lady living in England who, if it wasn’t for a CIRM-funded therapy, might not be living at all. She’s proof that what we do, is helping people. Thelma is featured in a video about a treatment for … Continue reading Seeing is believing. Proof a CIRM-funded therapy is making a difference
cancer
Alpha clinics and a new framework for accelerating stem cell treatments
Last week, at the World Stem Cell Summit in Miami, CIRM took part in a panel discussion about the role and importance of Alpha Clinics in not just delivering stem cell therapies, but in helping create a new, more collaborative approach to medicine. The Alpha Clinic concept is to create a network of top medical … Continue reading Alpha clinics and a new framework for accelerating stem cell treatments
Recap of the 2018 Alliance for Regenerative Medicine Cell and Gene Therapy State of the Industry
What happened in the Cell and Gene Therapy sector in 2017, and what should we be looking out for in 2018? Over 500 executives, investors, scientists and patient advocates gathered together yesterday to find out at the Alliance for Regenerative Medicine (ARM) State of the Industry Briefing in San Francisco, California. ARM Chairman, Robert Preti, … Continue reading Recap of the 2018 Alliance for Regenerative Medicine Cell and Gene Therapy State of the Industry
Harnessing the body’s immune system to tackle cancer
Often on the Stem Cellar we write about work that is in a clinical trial. But getting research to that stage takes years and years of dedicated work. Over the next few months, we are profiling some of the scientists we fund who are doing Discovery (early stage) and Translational (pre-clinical) research, to highlight the … Continue reading Harnessing the body’s immune system to tackle cancer
Scientists find switch that targets immunotherapies to solid tumors
Cancer immunotherapies harness the power of the patient’s own immune system to fight cancer. One type of immunotherapy, called adoptive T cell therapy, uses immune cells called CD8+ Killer T cells to target and destroy tumors. These T cells are made in the spleen and lymph nodes and they can migrate to different locations in … Continue reading Scientists find switch that targets immunotherapies to solid tumors
CIRM-Funded Research Makes Multiple Headlines this Week
When it rains it pours. This week, multiple CIRM-funded studies appeared in the news, highlighting the exciting progress our Agency is making towards funding innovative stem cell research and promoting the development of promising stem cell therapies for patients. Below are highlights. Fate Therapeutics Partners with UC San Diego to Develop Cancer Immunotherapy Last week, … Continue reading CIRM-Funded Research Makes Multiple Headlines this Week
Signal in Cancer Cells Points to New Immunotherapies
People usually mention the immune system when talking about colds or flu. Immune cells do fight viruses and bacteria, but they also destroy abnormal cancer cells inside the body. “Don’t Eat Me” Signal 101 A white blood cell called a macrophage is part of the innate immune system. It patrols tissues and engulfs infected and … Continue reading Signal in Cancer Cells Points to New Immunotherapies
Surprise findings about bone marrow transplants could lead to more effective stem cell therapies
Some medical therapies have been around for so long that we naturally assume we understand how they work. That’s not always the case. Take aspirin for example. It’s been used for more than 4,000 years to treat pain and inflammation but it was only in the 1970’s that we really learned how it works. The … Continue reading Surprise findings about bone marrow transplants could lead to more effective stem cell therapies
CIRM-Funded Clinical Trials Targeting Cancers
Welcome to the Month of CIRM! As we mentioned in last Thursday’s blog, during the month of October we’ll be looking back at what CIRM has done since the agency was created by the people of California back in 2004. To start things off, we’ll be focusing on CIRM-funded clinical trials this week. Supporting clinical … Continue reading CIRM-Funded Clinical Trials Targeting Cancers
Protein that turns normal cells into cancer stem cells to fight colon cancer
Colon cancer: Photo courtesy WebMD Now researchers may have identified a protein that causes normal cells to become cancerous, and turn into cancer stem cells (CSCs) to fight colon cancer. This discovery could help provide a new target for anti-cancer therapies. Fighting colon cancer More than one million people worldwide are diagnosed with colon cancer … Continue reading Protein that turns normal cells into cancer stem cells to fight colon cancer